Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese?

Journal of Public Health

Volumn 30, Issue 3, 2008, Pages 282-292

  Leung, Gabriel M ^a   Woo, Pauline P S ^a   Cowling, Benjamin J ^a   Tsang, Caroline S H ^b   Cheung, Annie N Y ^a   Ngan, Hextan Y S ^a   Galbraith, Kevin ^a   Lam, Tai Hing ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Breast cancer; Cervical cancer; DALYs; Iatrogenesis; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CONFIDENCE INTERVAL; EPIDEMIOLOGY; FEMALE; HONG KONG; HUMAN; IATROGENIC DISEASE; MASS SCREENING; MIDDLE AGED; RISK; UTERINE CERVIX TUMOR; UTILIZATION REVIEW;

ADULT; AGED; BREAST NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HEALTH CARE SURVEYS; HONG KONG; HUMANS; IATROGENIC DISEASE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; UTERINE CERVICAL NEOPLASMS;

EID: 54249127357     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdn034     Document Type: Article

References (56)

1. Clarke EA, Anderson TW. Does screening by Pap smears help prevent cervical cancer? A case-control study. Lancet 1979;2:1-4.
2. Laara E, Day N, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programs. Lancet 1987;1:1247-9.
3. Quinn M, Babb P, Jones J et al., on behalf of the United Kingdom Association of Cancer Registries. Effect of screening on incidence of the mortality from cancer of the cervix in England: evaluation based on routinely collected Statistics. Br Med J 1999;318:904-8.
4. Peto J, Gilham C, Fletcher O et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
5. Humphrey LL, Helfand M, Chan BKS. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:347-60.
6. Thomas DB, Gao DL, Ray RM et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94:1445-57.
7. Barton MB, Harris R, Fletcher SW. Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? JAMA 1999;282:1270-80.
8. Dickinson JA. Cervical screening: time to change the policy. Med J Aust 2002;176:547-50.
9. Shapiro S, Coleman EA, Broeders M et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 1998;27:735-42.
10. Calle EE, Flanders WD, Thun MJ et al. Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health 1993;83:53-60.
11. Mandelblatt JS, Gold K, O'Malley AS et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med 1999;28:418-25.
12. Lam TH, Ho SY, Hedley AJ et al. Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998. Br Med J 2001;323:361-2.
13. Leung GM, Thach TQ, Lam TH et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis (erratum appears in BJC 2003;88:2006).
14. Br J Cancer 2002;87:982-8.
15. Woo PPS, Thach TQ, Choy BST et al. Modeling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age-period-cohort approach. Br J Cancer 2005;93:1077-83.
16. Cancer Expert Working Group on Cancer Prevention and Screening. Report of Cancer Expert Working Group on Cancer Prevention and Screening. Department of Health, Government of the Hong Kong Special Administrative Region, People's Republic of China, 2004.
17. Leung GM, Thach TQ, Chan E et al. Short-, medium-, long-term and lifetime risks of developing and dying of breast cancer in a westernised Chinese population: evidence from Hong Kong between 1976 and 2000. Cancer 2004;103:501-8.
18. Leung GM, Lam TH, Thach TQ et al. Will screening mammography in the East do more harm than good? Am J Public Health 2002;92(11): 1841-6.
19. Leung GM, Lam TH, Hedley AJ. Screening mammography re-evaluated. Lancet 2000;355:750-1.
20. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.
21. Elmore JG, Reisch LM, Barton MB et al. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 2005;97:1035-43.
22. Leung GM, Wong IOL, Chan WS et al. The ecology of health care in Hong Kong. Soc Sci Med 2005;61:577-90.
23. University of Hong Kong. Population Health Survey Report. Commissioned by Department of Health, Government of the Hong Kong Special Administrative Region, People's Republic of China; 2005.
24. Last JM (ed). A Dictionary of Epidemiology. 4th edn. New York: Oxford University Press, 2001.
25. Murray CJ, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ 1994;72(3):481-94.
26. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994;72(3):495-509.
27. Hong Kong Census and Statistics Department. Hong Kong life tables 1996-2031. Government of the Hong Kong Special Administrative Region, People's Republic of China. Government Printers; 2004.
28. Mathers CD, Bernard C, Iburg K et al. The Global Burden of Disease in 2002: Data Sources, Methods and Results. Geneva: World Health Organization, 2003.
29. Hong Kong Census and Statistics Department. 2001 Population Census: Main Report. Government of the Hong Kong Special Administrative Region, People's Republic of China. Government Printers, 2001.
30. The Commonwealth Fund International Working Group on Quality Indicators. First Report and Recommendations of the Commonwealth Fund's International Working Group on Quality Indicators, June 2004.
31. Lo AY, Hedley AJ, Pei GK et al. Doctor-shopping in Hong Kong: implications for quality of care. Int J Qual Health Care 1994;6:371-81.
32. Leung GM, Castan-Cameo S, McGhee SM et al. Waiting time, doctor-shopping and non-attendance at specialist outpatient clinics: case-control study of 6,495 individuals in Hong Kong. Med Care 2003;41:1293-300.
33. Tudor Hart J. Three decades of the inverse care law. Br Med J 2000;320:18-9.
34. Hart JT. The inverse care law. Lancet 1971;1:405-12. 34 Gao J, Tang S, Tolhurst R et al. Changing access to health services in urban China: implications for equity. Health Policy Plan 2001;16:302- 12.
35. Gao J, Qian J, Tang S et al. Health equity in transition from planned to market economy in China. Health Policy Plan 2002;17(Suppl 1):20-9.
36. Harris R. Effectiveness: the next question for breast cancer screening. J Natl Cancer Inst 2005;97:1021-3.
37. Peto R, Boreham J, Clarke M et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000;355:1822.
38. Peto R. Trends in breast cancer incidence, survival, and mortality. Lancet 2000;356:593.
39. Kim JJ, Leung GM, Woo PP et al. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. J Public Health 2004;26:130-7.
40. Wong IOL, Kuntz KM, Leung GM. Is mammography screening cost-effective in Chinese women? A decision analytic approach. Abstract presented at the 5th World Congress of the International Health Economics Association, Barcelona, Spain; 2005.
41. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomar Prev 2005;14:1008-11.
42. Burstein HJ, Polyak K, Wong JS et al. Ductal carcinoma in situ of the breast. N Engl J Med 2004;350:1430-41.
43. Rohan TE, Burk RD, Franco EL. Toward a reduction of the global burden of cervical cancer. Am J Obstet Gynecol 2003;189:S37-9.
44. IARC Working Group on Evaluation of Cervical Cancer Screening Programs. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 1986;293:659-64.
45. Hong Kong Cancer Registry, Hospital Authority, Government of the Hong Kong Special Administrative Region, People's Republic of China. Age-Specific Cancer Incidence and Mortality Rates, 2001. http://www3.ha.org.hk/cancereg (Mar 2005, date last accessed).
46. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-2002). Bethesda, MD: National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch, April 2005.
47. Clinical Management System (CMS) and the Clinical Data Framework (CDF). Breast Cancer Stage Distribution 2001-2004. Hospital Authority, Government of the Hong Kong Special Administrative Region, People's Republic of China, 2004.
48. Renshaw AA, Young NA, Birdsong GG et al. Comparison of performance of conventional and ThinPrep gynaecologic preparations in the College of American Pathologists Gynaecologic Cytology Program. Arch Pathol Lab Med 2004;128:17-22.
49. Smith-Bindman R, Chu P, Miglioretti DL et al. Physician predictors of mammographic accuracy. J Natl Cancer Inst 2005;97:358-67.
50. The Hong Kong College of Obstetricians and Gynecologists. Guidelines on the Management of an Abnormal Cervical Smear. Number 3 (revised); November 2002.
51. Cheung ANY, Szeto EF, Ng KM et al. Atypical squamous cells of undetermined significance on cervical smears: follow-up study of an Asian screening population. Cancer 2004;102:74-80.
52. Cheung ANY, Szeto EF, Leung BSY et al. Liquid based cytology and conventional cervical smears: a comparison study in an Asian screening population. Cancer 2003;99:331-5.
53. Elmore JG, Barton MB, Moceri VM et al. Ten-year risk of positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-96.
54. Helvie MA, Ikeda DM, Adler DD. Localization and needle aspiration of breast lesions: complications in 370 cases. Am J Roentgenol 1991;157:711-4.
55. Mueller X, Amery A, Lallemand RC. Biopsy of mammographically-detected breast lesions in a district hospital. Eur J Surg Oncol 1993;19:415-9.
56. Kaelin CM, Smith TJ, Holmer MJ et al. Safety, accuracy, and diagnostic yield of needle localisation biopsy of the breast performed using local anaesthesia. J Am Coll Surg 1994;179:267-72.